FDA, Merck and Vioxx: Putting Patient Safety First? Hearing before the Senate Finance Committee

Transcript · David J. Graham; U.S. Senate Committee on Finance · November 18, 2004

Graham sharply criticized FDA’s safety structure in sworn Senate testimony concerning Vioxx. These were Graham’s testimony and opinions, not an FDA admission or a committee finding.

I would argue that the FDA, as currently configured, is incapable of protecting America against another Vioxx.

Graham written testimony, p. 4
Read the document (PDF)Official source

Graham sharply criticized FDA’s safety structure in sworn Senate testimony concerning Vioxx. These were Graham’s testimony and opinions, not an FDA admission or a committee finding. Bearing on the claim: partly supports. Verification note: Full official hearing record opened.

Election Day is Tuesday, Nov 3. Know who you're voting for: your values vs. their record, with sources.Build my Vote Card →